Amgen appeals against PTAB Sanofi decision
Amgen subsidiary Immunex has appealed against a Patent Trial and Appeal Board decision which invalidated a patent claiming antibodies that target human interleukin-4 receptors.
AG weighs in on Bayer patent case
An advocate general has advised the Court of Justice of the European Union on damages in a case between Bayer and pharmaceutical companies Richter and Exeltis.
EU complains to WTO over Turkey’s pharma measures
The European Union has asked the World Trade Organization to initiate dispute consultations with Turkey over requirements imposed by the country on pharmaceutical products.
China, Canada and US labs collaborate over neurological disorder therapies
Chinese companies have entered into a research agreement with scientists in the US and Canada to develop a therapy for neurological disorders by using the natural power of the immune system.
FTC approves Fresenius’s $2bn acquisition of NxStage Medical
The US Federal Trade Commission has issued a final approval of Fresenius Medical Care’s $2 billion acquisition of medical device company NxStage Medical.
Duane Morris hires Winston & Strawn lawyer
Duane Morris & Selvam has strengthened its IP practice with the addition of John Alison from Winston & Strawn.
Athena asks for rehearing on invalidated neurological disorder patent
Athena Diagnostics has asked the US Federal Circuit to revisit its decision earlier this year, which found four claims in one of its patents to be invalid.
Alnylam and Regeneron unveil RNAi partnership
Pharmaceutical companies Alnylam and Regeneron will collaborate on the development and commercialisation of RNA interference therapeutics.
Sun Pharma takes Pfizer to court over Lyrica
India-based drugmaker Sun Pharma has accused Pfizer of infringing a patent with a new extended-release formulation of Lyrica.
FDA boosts customs collaboration to fight fake drugs
The US Food and Drug Administration and US Customs and Border Protection have strengthened their collaboration in a bid to halt the import of counterfeit drugs and protect public health.
